AMBIENTUM BIOETHICA BIOLOGIA CHEMIA DIGITALIA DRAMATICA EDUCATIO ARTIS GYMNAST. ENGINEERING EPHEMERIDES EUROPAEA GEOGRAPHIA GEOLOGIA HISTORIA HISTORIA ARTIUM INFORMATICA IURISPRUDENTIA MATHEMATICA MUSICA NEGOTIA OECONOMICA PHILOLOGIA PHILOSOPHIA PHYSICA POLITICA PSYCHOLOGIA-PAEDAGOGIA SOCIOLOGIA THEOLOGIA CATHOLICA THEOLOGIA CATHOLICA LATIN THEOLOGIA GR.-CATH. VARAD THEOLOGIA ORTHODOXA THEOLOGIA REF. TRANSYLVAN
Rezumat articol ediţie STUDIA UNIVERSITATIS BABEŞ-BOLYAI
În partea de jos este prezentat rezumatul articolului selectat. Pentru revenire la cuprinsul ediţiei din care face parte acest articol, se accesează linkul din titlu. Pentru vizualizarea tuturor articolelor din arhivă la care este autor/coautor unul din autorii de mai jos, se accesează linkul din numele autorului.
Autori: IRINA KACSO, IOANA BÂLDEA, MARIA MICLĂUȘ, AUGUSTIN MOȚ, REMUS MOLDOVAN, FLAVIA MARTIN.
DOI: 10.24193/subbchem.2023.4.10
Published Online: 2023-12-20
Published Print: 2023-12-30
pp. 137-154
VIEW PDF
FULL PDF
The current study investigates the potential of the supramolecular complex between the antifungal agent Ketoconazole (KTZ) and PAMAM dendrimer G5 generation to be used as a topically applied antimycotic drug. The new drug-dendrimer formulation was confirmed by combining XRPD, FT-IR and DSC analytical techniques, and presents improved aqueous solubility and delayed in vitro release profile compare to pure KTZ. The biological assays data showed the biocompatibility of the supramolecular complex and improved delivery of the encapsulated KTZ into the superficial layers of skin and mucosa at the mycotic infections site, leading to a better outcome of the infection.
Keywords: Ketoconazole, PAMAM dendrimer, Drug-dendrimer complex, Solubility, Cell viability, Mouse ear sensitization test
